BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9154166)

  • 21. Cancer chemoprevention drug targets.
    Krishnan K; Campbell S; Abdel-Rahman F; Whaley S; Stone WL
    Curr Drug Targets; 2003 Jan; 4(1):45-54. PubMed ID: 12528989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
    Meyskens FL; Gerner EW
    Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
    Pereira MA
    Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of lung cancers: lessons from CARET, the beta-carotene and retinol efficacy trial, and prospects for the future.
    Omenn GS
    Eur J Cancer Prev; 2007 Jun; 16(3):184-91. PubMed ID: 17415088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoids in chemoprevention and differentiation therapy.
    Hansen LA; Sigman CC; Andreola F; Ross SA; Kelloff GJ; De Luca LM
    Carcinogenesis; 2000 Jul; 21(7):1271-9. PubMed ID: 10874003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micronutrients in cancer chemoprevention.
    Greenwald P; Milner JA; Anderson DE; McDonald SS
    Cancer Metastasis Rev; 2002; 21(3-4):217-30. PubMed ID: 12549762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker end-points in cancer chemoprevention trials.
    Boone CW; Kelloff GJ
    IARC Sci Publ; 1997; (142):273-80. PubMed ID: 9354926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of clinical cancer chemoprevention studies with emphasis on positive phase III studies.
    Alberts DS; Garcia DJ
    J Nutr; 1995 Mar; 125(3 Suppl):692S-697S. PubMed ID: 7884553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative tissue-specific toxicities of 20 cancer preventive agents using cultured cells from 8 different normal human epithelia.
    Elmore E; Luc TT; Steele VE; Redpath JL
    In Vitr Mol Toxicol; 2001; 14(3):191-207. PubMed ID: 11846992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of epithelial cancers.
    Shureiqi I; Brenner DE
    Curr Opin Oncol; 1999 Sep; 11(5):408-13. PubMed ID: 10505781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention.
    Niles RM
    Acta Pharmacol Sin; 2007 Sep; 28(9):1383-91. PubMed ID: 17723172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
    Boone CW; Kelloff GJ; Malone WE
    Cancer Res; 1990 Jan; 50(1):2-9. PubMed ID: 2403415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoprevention of prostate cancer: concepts and strategies.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovitch L; Malone WA; Crowell JA; Sigman CC
    Eur Urol; 1999; 35(5-6):342-50. PubMed ID: 10325487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical evaluation of cancer prevention agents.
    Goodman GE
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):253-9. PubMed ID: 9349694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer chemoprevention.
    Lippman SM; Benner SE; Hong WK
    J Clin Oncol; 1994 Apr; 12(4):851-73. PubMed ID: 8151328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.